Abstract
Butylated hydroxytoluene (BHT, 2,6-di-tert-butyl-4-methyl-phenol) is a commonly used antioxidant allowed in foods in amounts up to 0.02% of the weight of fat present. BHT helps prevent undesirable oxidation reactions from occurring by acting as a free radical scavenger. BHT is also used as a stabilizer in pesticides, gasolines and lubricants, soaps and cosmetics, and as an antiskinning agent in paints and inks (1). BHT has been shown to have a protective effect against the toxicity and carcinogenicity of a wide variety of chemicals (2). However, several recent animal studies have questioned the presumed safety of this antioxidant. For example, BHT has been shown to cause lung damage in mice (3,4), hemorrhagic death in rats (5) and can act as a tumor promoter in both mice and rats (6,7). One of the best characterized toxic effects of BHT is the destruction of type I alveolar and pulmonary endothelial cells (8) in the mouse lung. This lung damage is thought to arise from the biotransformation of BHT into BHT-quinone methide (2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone) (9,10), a highly reactive compound (see Figure 1). BHT has been demonstrated to be metabolized to BHT-quinone methide in vivo in the mouse (10) and rat (11). This reaction is presumably catalyzed by a cytochrome P-450 related enzyme (12,13). As a class of chemical compounds, quinone methides have been shown to react with cellular nucleophiles including amines, carbohydrates, alcohols, thiols, and olefins (14).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Clinical Toxicology of Commercial Products, 5th Ed., R.E. Gosselin, R.P. Smith and H.C. Hodge, eds., Williams and Wilkins, Baltimore (1984).
H. Babich, Butylated hydroxytoluene (BHT): A review, Environ. Res. 29: 1 (1982).
A.A. Marino and J.T. Mitchell, Lung damage in mice following intraperitoneal injection of butylated hydroxytoluene, Proc. Soc. Exp. Biol. Med. 140: 122 (1972).
H. Witschi and W. Saheb, Stimulation of DNA synthesis in mouse lung following intraperitoneal injection of butylated hydroxytoluene, Proc. Soc. Exp. Biol. Med. 147: 690 (1974).
G. Takahashi and K. Kiraga, Dose-response study of hemorrhagic death by dietary butylated hydroxytoluene (BHT) in male rats, Tox. Appl. Pharmacol. 43: 399 (1978).
H.P. Witschi, Enhancement of lung tumor formation in mice, in: “Carcinogenesis”, M.J. Mass, et al., eds., Raven Press, New York (1985).
K. Imaida, S. Fukushima, T. Shirai, T. Masui, T. Ogiso and N. Ito, Promoting activities of butylated hydroxyanisole, butylated hydroxytoluene and sodium L-ascorbate on forestomach and urinary bladder carcinogenesis initiated with methylnitrosourea in F344 male rats, Gann 75: 769 (1984).
L.J. Smith, The effect of methylprednisolone on lung injury in mice, J. Lab. Clin. Med. 101: 629 (1983).
T. Mizutani, I. Ishida, K. Yamamoto and K. Tajima, Pulmonary toxicity of butylated hydroxytoluene and related alkyl-phenols: Structural requirements for toxic potency in mice, Tox. Appl. Pharmacol. 62: 273 (1982).
T. Mizutani, K. Yamamoto and K. Tajima, Isotope effects on the metabolism and pulmonary toxicity of butylated hydroxytoluene in mice by deuteration of the 4-methyl group, Tox. Appl. Pharmacol. 69: 283 (1983).
Takahashi and K. Hiraga, 2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone: A hepatic metabolite of butylated hydroxytoluene in rats, Fd. Cosmet. Toxicol. 17: 451 (1979).
J.P. Kehrer and H. Witschi, Effects of drug metabolism inhibitors on butylated hydroxytoluene-induced pulmonary toxicity in mice, Tox. Appl. Pharmacol. 53: 333 (1980).
K. Tajima, K. Yamamoto and T. Mizutani, Formation of a glutathione conjugate from butylated hydroxytoluene by rat liver microsomes, Biochem. Pharmacol. 34: 2109 (1985).
A.B. Turner, Quinone methides, Quart. Rev. 18: 347 (1964).
L.J. Marnett and T.E. Eling, Cooxidation during prostaglandin biosynthesis: A pathway for the metabolic activation of xenobiotics, in: “Reviews in Biochemical Toxicology, 5,”, E. Hodgson and J.R. Bond, eds., Elsevier Biomedical, New York (1983).
S.M. Cohen, T.V. Zenser, G. Muraski, S. Fukushima, M.B. Mattammal, N.S. Rapp and B.B. Davis, Aspirin inhibition of N-(4-[5-nitro-2-furyl]-2thiazolyl)formamide-induced lesions of the urinary bladder correlated with inhibition of metabolism by bladder prostaglandin endoperoxide synthetase, Cancer Res. 41: 3355 (1981).
H. Lowry, N.J. Rosebrough, A.L. Farr and R.J. Randall, Protein measurement with the Folin phenol reagent, J. Biol. Chem. 193: 265 (1951).
H. Becker, Quinone dehydrogenation. I. The oxidation of monohydric phenols, J. Org. Chem. 30: 982 (1965).
C.D. Cook, N.G. Nash and H.R. Flanagan, Oxidation of hindered phenols. III. The rearrangement of the 2,6-di-t-butyl-4-methylphenoxy radical, J. Amer. Chem. Soc. 77: 1783 (1955).
T. Kurechi and T. Kato, Studies on the antioxidants. XX. The effect of butylated hydroxytoluene on tert-butylhydroperoxide-induced oxidation of butylated hydroxyanisole, Chem. Pharm. Bull. 31: 1772 (1983).
G.A. Reed, E.A. Brooks and T.E. Eling, Phenylbutazone-dependent epoxidation of 7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, J. Biol. Chem. 259: 5591 (1984).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Plenum Press, New York
About this chapter
Cite this chapter
Thompson, D.C., Cha, Y.N., Trush, M.A. (1986). The Peroxidative Activation of Butylated Hydroxytoluene to BHT-Quinone Methide and Stilbenequinone. In: Kocsis, J.J., Jollow, D.J., Witmer, C.M., Nelson, J.O., Snyder, R. (eds) Biological Reactive Intermediates III. Advances in Experimental Medicine and Biology, vol 197. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5134-4_27
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5134-4_27
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5136-8
Online ISBN: 978-1-4684-5134-4
eBook Packages: Springer Book Archive